Commentary on ‘Stroke/Death Rates Following Carotid Artery Stenting and Carotid Endarterectomy in Contemporary Administrative Dataset Registries: A Systematic Review’  by Ricco, J.-B.
Eur J Vasc Endovasc Surg (2016) 51, 13INVITED COMMENTARYCommentary on ‘Stroke/Death Rates Following Carotid Artery Stenting and
Carotid Endarterectomy in Contemporary Administrative Dataset Registries:
A Systematic Review’
J.-B. Ricco
Department of Vascular Surgery, University Hospital of Poitiers, Poitiers, FranceA MATTER OF CONCERN
The aim of the study by Paraskevas et al.1 was to compare stroke/
death rates after CAS/CEA in contemporary dataset registries, to
determine whether they fall within the AHA thresholds and if they
had declined over time.
The authors reviewed 21 registries published between January
2008 and February 2015. Datasets were speciﬁcally searched for
outcome according to whether patients were termed “high risk” or
“average risk” for CEA according to the criteria published in the
SAPPHIRE trial.2AVERAGE MEDICAL RISK
Among 21 registries in asymptomatic “average risk” patients, CAS
was associated with a higher stroke/death rates than CEA in 16
(76%), while in ﬁve registries CAS was associated with similar rates.
Furthermore, in nine registries (43%), CAS exceeded the 3%
threshold limit recommended by the AHA/ASA for asymptomatic
patients.3
The same trend in favour of CEA was observed in 16 out of 18
(88%) registries for “average risk” symptomatic patients with a risk
greater than 10% for CAS in ﬁve registries.
In neither of these two groups was there any evidence of
decline over time in procedural risk after CAS.HIGH MEDICAL RISK
Among three dataset registries reporting outcomes after CAS/CEA
in high risk asymptomatic patients, two reported higher stroke/
death rates after CAS than CEA. The same trend was observed in
high risk symptomatic patients.
The AHA/ASA decision to broaden CAS indications, based on
CREST data,4 had suggested that contemporary CAS outcomes fall
within accepted thresholds. The review by Paraskevas et al.1 shows
that this is not the case. By stratifying patients according to
symptoms and medical risk status, it allows for useful comparisons
between CAS and CEA. The authors demonstrate that following
CAS compared with CEA, there is an increased risk of stroke or
death in symptomatic and asymptomatic patients with average as
well as high medical risk. This is particularly true among symp-
tomatic medically high risk patients with a 9.3% peri-proceduralDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.07.032
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Furthermore, evidence suggests that the risk of stroke after a
TIA is front loaded with the highest risk period being the ﬁrst 14
days after onset of symptoms.6 The largest study to compare
outcomes during the acute period after the onset of symptoms
comes from a meta-analysis of the three European RCTs. In this
study, patients undergoing CAS 7 days after symptoms exhibited
a 9.4% rate of death/stroke compared with 2.8% for patients un-
dergoing CEA during the same period.7 This key issue arising from
pooled RCTs has been underscored by this review of contemporary
dataset registries.
While the clinical pitfalls of administrative datasets are well
known (selection bias, potential coding errors), in this case these
datasets reﬂect actual practice and allow for reliable comparisons
between CEA and CAS.
Because of the similarities between the CEA adverse events
rates recorded in these registries and RCTs, the signiﬁcantly greater
proportion of adverse events observed among CAS patients in
these registries remains a matter of concern.REFERENCES
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